(Q46823402)

25 December 2017

title

Long-term outcomes in patients with severe sepsis randomised to resuscitation with hydroxyethyl starch 130/0.42 or Ringer's acetate (English)

1 reference

25 December 2017

0 references

1 reference

1

1 reference

25 December 2017

Anders Aneman

8

1 reference

25 December 2017

Jørn Wetterslev

9

1 reference

25 December 2017

Anne Berit Guttormsen

4

Anne B Guttormsen

1 reference

25 December 2017

Nicolai Haase

2

Nicolai Haase

1 reference

25 December 2017

Gudmundur Klemenzson

6

Gudmundur Klemenzson

1 reference

25 December 2017

Per Winkel

3

Per Winkel

1 reference

25 December 2017

Rasmus Beier Müller

7

Rasmus G Müller

1 reference

25 December 2017

author name string

Jyrki Tenhunen

5

1 reference

25 December 2017

publication date

8 May 2014

1 reference

25 December 2017

published in

Intensive Care Medicine

1 reference

25 December 2017

volume

40

1 reference

25 December 2017

issue

7

1 reference

25 December 2017

page(s)

927-934

1 reference

25 December 2017

https://scigraph.springernature.com/pub.10.1007/s00134-014-3311-y

exact match

0 references

cites work

Intensive insulin therapy and pentastarch resuscitation in severe sepsis

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3311-Y

Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3311-Y

Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3311-Y

Hydroxyethyl starch or saline for fluid resuscitation in intensive care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3311-Y

Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3311-Y

Randomised trials of 6% tetrastarch (hydroxyethyl starch 130/0.4 or 0.42) for severe sepsis reporting mortality: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3311-Y

Year in review in Intensive Care Medicine 2013: I. Acute kidney injury, ultrasound, hemodynamics, cardiac arrest, transfusion, neurocritical care, and nutrition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3311-Y

Fluid resuscitation with 6 % hydroxyethyl starch (130/0.4 and 130/0.42) in acutely ill patients: systematic review of effects on mortality and treatment with renal replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3311-Y

Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3311-Y

Accumulation of hydroxyethyl starch in human and animal tissues: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3311-Y

Influence of hydroxyethyl starch (HES) 130/0.4 on hemostasis as measured by viscoelastic device analysis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3311-Y

Bleeding and risk of death with hydroxyethyl starch in severe sepsis: post hoc analyses of a randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3311-Y

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3311-Y

Re-evaluating currently available data and suggestions for planning randomised controlled studies regarding the use of hydroxyethyl starch in critically ill patients - a multidisciplinary statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3311-Y

Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3311-Y

Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure, etc.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3311-Y

Sepsis in European intensive care units: results of the SOAP study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3311-Y

Are small hospitals with small intensive care units able to treat patients with severe sepsis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3311-Y

American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3311-Y

Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3311-Y

Does acute organ dysfunction predict patient-centered outcomes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3311-Y

Hydroxyethyl starch: putting patient safety first

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3311-Y

Quality of life and pruritus in patients with severe sepsis resuscitated with hydroxyethyl starch long-term follow-up of a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-014-3311-Y

Effects of hydroxyethyl starch in subgroups of patients with severe sepsis: exploratory post-hoc analyses of a randomised trial

21 January 2018

1 reference

12 December 2020

Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function

1 reference

12 December 2020

Mortality in patients with hypovolemic shock treated with colloids or crystalloids

1 reference

12 December 2020

A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study

1 reference

12 December 2020

American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis

1 reference

12 December 2020

The effect of drotrecogin alfa (activated) on long-term survival after severe sepsis

1 reference

12 December 2020

The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine

1 reference

12 December 2020

10.1007/S00134-014-3311-Y

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017